Livongo
Livongo Raises $142M in Series D
Livongo Raises $142M in Series D
Livongo has successfully raised $142M in a Series D at a $1.1B valuation led by General Catalyst, Kleiner Perkins.
Company Overview
Livongo is a HealthTech company headquartered in Mountain View, CA, founded in 2014 with 800+ employees.
Digital health management for chronic conditions
Fundraising Details
- Amount Raised: $142M
- Round Type: Series D
- Valuation: $1.1B
- Date: 2018-07-17
- Investors: General Catalyst, Kleiner Perkins
About Livongo
Digital health management for chronic conditions The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Mountain View, CA
- Founded: 2014
- Team Size: 800+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Livongo's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Livongo's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1.1B valuation marks an important milestone for Livongo, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Livongo is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2018-07-17. For more information about Livongo, visit their headquarters at Mountain View, CA.
Company Info
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free